Betoptic S Suspension/ Drops
Product Images NDC 0078-0729

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Betoptic S (NDC 0078-0729). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel Ndc 0078-0729-10 Betoptic S® (betaxolol Hci Ophthalmic Suspension) 0.25% As Base 10 mL Sterile Novartis (Carton)

Packaging label for Betoptic S ophthalmic suspension, containing betaxolol hydrochloride 0.25% as base. The label indicates a 10 mL sterile suspension in drop form. It is distributed by Novartis Pharmaceuticals Corporation and manufactured by Alcon Laboratories, Inc. The label includes storage, usage, and dosage information along with barcodes and lot/expiration details.*

FDA Label Image

Chemical (Chemical)

Chemical structure diagram of betaxolol hydrochloride, showing its molecular framework including functional groups and hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.